pulmonary-hypertension

Documents about pulmonary-hypertension

• Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension#377292ClinicalTrials.gov
• Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil#414395ClinicalTrials.gov
• Registry of Preterm Newborns With Severe Pulmonary Hypertension#429643ClinicalTrials.gov
• Remote Exercise Testing in Patients With Pulmonary Hypertension#856001ClinicalTrials.gov
• Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension#901237ClinicalTrials.gov
• Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis#967168ClinicalTrials.gov
• Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients#995041ClinicalTrials.gov
• Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension#896711ClinicalTrials.gov
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years#991778ClinicalTrials.gov
• Repurposing Valsartan May Protect Against Pulmonary Hypertension#272466ClinicalTrials.gov
• Sildenafil and Pulmonary Artery Pressure#899301ClinicalTrials.gov
• Sotatercept in Pulmonary Arterial Hypertension#995210ClinicalTrials.gov
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension#806446ClinicalTrials.gov
• REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management#982190ClinicalTrials.gov
• Catheter Ablation of Atrial Fibrillation in Patients With Pulmonary Hypertension Hypertension: a Randomised Study#390994ClinicalTrials.gov
• Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases#28447ClinicalTrials.gov
• TReatment of Pulmonary Hypertension Group II Study#123602ClinicalTrials.gov
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension#125999ClinicalTrials.gov
• Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension#146296ClinicalTrials.gov
• Pulmonary Hypertension: Intensification and Personalisation of Combination Rx#154771ClinicalTrials.gov
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension#158083ClinicalTrials.gov
• The Role of miRNA in Group 3 Pulmonary Hypertension#195431ClinicalTrials.gov
• The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension#195448ClinicalTrials.gov
• A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.#208316ClinicalTrials.gov
• The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension#245366ClinicalTrials.gov
• Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension#256981ClinicalTrials.gov
• Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)#268113ClinicalTrials.gov
• A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension#383648ClinicalTrials.gov
• Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension#435805ClinicalTrials.gov
• Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension#623586ClinicalTrials.gov
• Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)#843788ClinicalTrials.gov
• FK506 (Tacrolimus) in Pulmonary Arterial Hypertension#851149ClinicalTrials.gov
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)#842791ClinicalTrials.gov
• Effectiveness and Tolerance of Respiratory Rehabilitation in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease#853925ClinicalTrials.gov
• Effect of Short-term Oxygen During CPET in Pulmonary Hypertension#321608ClinicalTrials.gov
• Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension#837390ClinicalTrials.gov
• Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension#839944ClinicalTrials.gov
• Aerobic Exercise in Patients With Pulmonary Hypertension#858277ClinicalTrials.gov
• China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization#966615ClinicalTrials.gov
• Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension#890655ClinicalTrials.gov
• Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)#895408ClinicalTrials.gov
• Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching#803128ClinicalTrials.gov
• Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease#981912ClinicalTrials.gov
• A nUtrition and Lifestyle Intervention in Patients With Pulmonary Arterial HypertensIon#18768ClinicalTrials.gov
• Exercise and Respiratory Training as Supportive Treatments for Patients With Chronic Pulmonary Hypertension#125984ClinicalTrials.gov
• Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study#126002ClinicalTrials.gov
• The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study#136181ClinicalTrials.gov
• Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension#148641ClinicalTrials.gov
• Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease#175008ClinicalTrials.gov
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension#180260ClinicalTrials.gov